Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Autologous Cell Therapy Market Size Growth Rate by Type (2014-2025)
1.4.2 Bone Marrow
1.4.3 Epidermis
1.5 Market by Application
1.5.1 Global Autologous Cell Therapy Market Share by Application (2019-2025)
1.5.2 Neurology
1.5.3 Orthopedics
1.5.4 Cancer
1.5.5 Wound Healing
1.5.6 Other
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Autologous Cell Therapy Market Size
2.2 Autologous Cell Therapy Growth Trends by Regions
2.2.1 Autologous Cell Therapy Market Size by Regions (2019-2025)
2.2.2 Autologous Cell Therapy Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
3 Market Share by Key Players
3.1 Autologous Cell Therapy Market Size by by Players
3.1.1 Global Autologous Cell Therapy Revenue by by Players (2014-2019)
3.1.2 Global Autologous Cell Therapy Revenue Market Share by by Players (2014-2019)
3.1.3 Global Autologous Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.2 Autologous Cell Therapy Key Players Head office and Area Served
3.3 Key Players Autologous Cell Therapy Product/Solution/Service
3.4 Date of Enter into Autologous Cell Therapy Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Autologous Cell Therapy Market Size by Type (2014-2019)
4.2 Global Autologous Cell Therapy Market Size by Application (2014-2019)
5 North America
5.1 North America Autologous Cell Therapy Market Size (2014-2019)
5.2 Autologous Cell Therapy Key Players in North America
5.3 North America Autologous Cell Therapy Market Size by Type
5.4 North America Autologous Cell Therapy Market Size by Application
6 Europe
6.1 Europe Autologous Cell Therapy Market Size (2014-2019)
6.2 Autologous Cell Therapy Key Players in Europe
6.3 Europe Autologous Cell Therapy Market Size by Type
6.4 Europe Autologous Cell Therapy Market Size by Application
7 China
7.1 China Autologous Cell Therapy Market Size (2014-2019)
7.2 Autologous Cell Therapy Key Players in China
7.3 China Autologous Cell Therapy Market Size by Type
7.4 China Autologous Cell Therapy Market Size by Application
8 Japan
8.1 Japan Autologous Cell Therapy Market Size (2014-2019)
8.2 Autologous Cell Therapy Key Players in Japan
8.3 Japan Autologous Cell Therapy Market Size by Type
8.4 Japan Autologous Cell Therapy Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Autologous Cell Therapy Market Size (2014-2019)
9.2 Autologous Cell Therapy Key Players in Southeast Asia
9.3 Southeast Asia Autologous Cell Therapy Market Size by Type
9.4 Southeast Asia Autologous Cell Therapy Market Size by Application
10 India
10.1 India Autologous Cell Therapy Market Size (2014-2019)
10.2 Autologous Cell Therapy Key Players in India
10.3 India Autologous Cell Therapy Market Size by Type
10.4 India Autologous Cell Therapy Market Size by Application
11 Central & South America
11.1 Central & South America Autologous Cell Therapy Market Size (2014-2019)
11.2 Autologous Cell Therapy Key Players in Central & South America
11.3 Central & South America Autologous Cell Therapy Market Size by Type
11.4 Central & South America Autologous Cell Therapy Market Size by Application
12 International Players Profiles
12.1 BioTime
12.1.1 BioTime Company Details
12.1.2 Company Description and Business Overview
12.1.3 Autologous Cell Therapy Introduction
12.1.4 BioTime Revenue in Autologous Cell Therapy Business (2014-2019))
12.1.5 BioTime Recent Development
12.2 Pharmicell
12.2.1 Pharmicell Company Details
12.2.2 Company Description and Business Overview
12.2.3 Autologous Cell Therapy Introduction
12.2.4 Pharmicell Revenue in Autologous Cell Therapy Business (2014-2019)
12.2.5 Pharmicell Recent Development
12.3 BrainStorm Cell Therapeutics
12.3.1 BrainStorm Cell Therapeutics Company Details
12.3.2 Company Description and Business Overview
12.3.3 Autologous Cell Therapy Introduction
12.3.4 BrainStorm Cell Therapeutics Revenue in Autologous Cell Therapy Business (2014-2019)
12.3.5 BrainStorm Cell Therapeutics Recent Development
12.4 Opexa Therapeutics
12.4.1 Opexa Therapeutics Company Details
12.4.2 Company Description and Business Overview
12.4.3 Autologous Cell Therapy Introduction
12.4.4 Opexa Therapeutics Revenue in Autologous Cell Therapy Business (2014-2019)
12.4.5 Opexa Therapeutics Recent Development
12.5 Vericel Corporation
12.5.1 Vericel Corporation Company Details
12.5.2 Company Description and Business Overview
12.5.3 Autologous Cell Therapy Introduction
12.5.4 Vericel Corporation Revenue in Autologous Cell Therapy Business (2014-2019)
12.5.5 Vericel Corporation Recent Development
12.6 Regeneus
12.6.1 Regeneus Company Details
12.6.2 Company Description and Business Overview
12.6.3 Autologous Cell Therapy Introduction
12.6.4 Regeneus Revenue in Autologous Cell Therapy Business (2014-2019)
12.6.5 Regeneus Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
【掲載企業】
BioTime、Pharmicell、BrainStorm Cell Therapeutics、Opexa Therapeutics、Vericel Corporation、Regeneus
【免責事項】
https://www.globalresearch.jp/disclaimer